Terms: = Bone cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Treatment
25 results:
1. Zoledronic acid-associated osteonecro sis of the jaw in patients with EGFR-sensitive mutant lung cancer: two case reports.
Aosiman A; Nuermaimaiti G; Yuan M; Liu J; Aerxiding P
Anticancer Drugs; 2023 Mar; 34(3):467-471. PubMed ID: 36730302
[TBL] [Abstract] [Full Text] [Related]
2. Function and return to sports after proximal humeral replacement in patients with primary bone sarcoma.
Ellerbrock M; Theil C; Gosheger G; Deventer N; Klingebiel S; Rickert C; Schneider KN
J Orthop Traumatol; 2022 Dec; 23(1):59. PubMed ID: 36571630
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment.
Jiang Y; Wang J; Sun M; Zuo D; Wang H; Shen J; Jiang W; Mu H; Ma X; Yin F; Lin J; Wang C; Yu S; Jiang L; Lv G; Liu F; Xue L; Tian K; Wang G; Zhou Z; Lv Y; Wang Z; Zhang T; Xu J; Yang L; Zhao K; Sun W; Tang Y; Cai Z; Wang S; Hua Y
Nat Commun; 2022 Nov; 13(1):7207. PubMed ID: 36418292
[TBL] [Abstract] [Full Text] [Related]
4. Staging Investigations in Asymptomatic Early Breast cancer Patients at the cancer Centre of Southeastern Ontario.
Kamel D; Youssef V; Hopman WM; Mates M
Curr Oncol; 2021 Jun; 28(3):2190-2198. PubMed ID: 34204717
[TBL] [Abstract] [Full Text] [Related]
5. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract] [Full Text] [Related]
6. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
[TBL] [Abstract] [Full Text] [Related]
7. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.
Wang HH; Cui YL; Zaorsky NG; Lan J; Deng L; Zeng XL; Wu ZQ; Tao Z; Guo WH; Wang QX; Zhao LJ; Yuan ZY; Lu Y; Wang P; Meng MB
Cancer Lett; 2016 Jun; 375(2):349-359. PubMed ID: 26996301
[TBL] [Abstract] [Full Text] [Related]
8. Radiographic Local Control of Spinal Metastases with Percutaneous Radiofrequency Ablation and Vertebral Augmentation.
Wallace AN; Tomasian A; Vaswani D; Vyhmeister R; Chang RO; Jennings JW
AJNR Am J Neuroradiol; 2016 Apr; 37(4):759-65. PubMed ID: 26635286
[TBL] [Abstract] [Full Text] [Related]
9. CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.
Eilers G; Czaplinski JT; Mayeda M; Bahri N; Tao D; Zhu M; Hornick JL; Lindeman NI; Sicinska E; Wagner AJ; Fletcher JA; Mariño-Enriquez A
Mol Cancer Ther; 2015 Jun; 14(6):1346-53. PubMed ID: 25852058
[TBL] [Abstract] [Full Text] [Related]
10. Porcine small intestine submucosal grafts for post-tumor resection orbital reconstruction.
Phillips J; Riley KO; Woodworth BA
Laryngoscope; 2014 Jun; 124(6):E219-23. PubMed ID: 24214917
[TBL] [Abstract] [Full Text] [Related]
11. The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4.
Zhou H; Yang YH; Basile JR
Angiogenesis; 2014 Jan; 17(1):261-74. PubMed ID: 24114199
[TBL] [Abstract] [Full Text] [Related]
12. Four cases of solitary fibrous tumour of the eye and orbit: one with sarcomatous transformation after radiotherapy and one in a 5-year-old child's eyelid.
Blandamura S; Alaggio R; Bettini G; Guzzardo V; Valentini E; Bedogni A
J Clin Pathol; 2014 Mar; 67(3):263-7. PubMed ID: 24108432
[TBL] [Abstract] [Full Text] [Related]
13. Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.
Pham MH; Zada G; Mosich GM; Chen TC; Giannotta SL; Wang K; Mack WJ
Neurosurg Focus; 2011 May; 30(5):E7. PubMed ID: 21529178
[TBL] [Abstract] [Full Text] [Related]
14. treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.
Rutkowski P; Dębiec-Rychter M; Nowecki Z; Michej W; Symonides M; Ptaszynski K; Ruka W
J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):264-70. PubMed ID: 20569296
[TBL] [Abstract] [Full Text] [Related]
15. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.
Rutkowski P; Van Glabbeke M; Rankin CJ; Ruka W; Rubin BP; Debiec-Rychter M; Lazar A; Gelderblom H; Sciot R; Lopez-Terrada D; Hohenberger P; van Oosterom AT; Schuetze SM; ;
J Clin Oncol; 2010 Apr; 28(10):1772-9. PubMed ID: 20194851
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas.
Tamborini E; Virdis E; Negri T; Orsenigo M; Brich S; Conca E; Gronchi A; Stacchiotti S; Manenti G; Casali PG; Pierotti MA; Pilotti S
Neuro Oncol; 2010 Aug; 12(8):776-89. PubMed ID: 20164240
[TBL] [Abstract] [Full Text] [Related]
17. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
[TBL] [Abstract] [Full Text] [Related]
18. Expression study of the target receptor tyrosine kinase of Imatinib mesylate in skull base chordomas.
Orzan F; Terreni MR; Longoni M; Boari N; Mortini P; Doglioni C; Riva P
Oncol Rep; 2007 Jul; 18(1):249-52. PubMed ID: 17549375
[TBL] [Abstract] [Full Text] [Related]
19. [Dermatofibrosarcoma protuberans].
Sanmartín O; Llombart B; López-Guerrero JA; Serra C; Requena C; Guillén C
Actas Dermosifiliogr; 2007 Mar; 98(2):77-87. PubMed ID: 17397592
[TBL] [Abstract] [Full Text] [Related]
20. Participation of epidermal langerhans cells in human pathology and their potential as targets for drug development: a review of literature.
Ayala-García I; Hernández-Segura AM; Castell-Rodríguez A; Alvarez Pérez SJ; Téllez BH; Ramírez-González MD
Proc West Pharmacol Soc; 2005; 48():13-20. PubMed ID: 16416652
[TBL] [Abstract] [Full Text] [Related]
[Next]
